Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Clasificación en acciones #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$150.00
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Poniard Pharmaceuticals, Inc. (PARD)

Categoría

Precio PARD con Capital del mercado a B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Capitalización de mercado de Poniard Pharmaceuticals, Inc.(PARD)
Capitalización bursátil: $150.00
A fecha de August 2026, Poniard Pharmaceuticals, Inc. tiene una capitalización de mercado de $150.00. Esto convierte a Poniard Pharmaceuticals, Inc. en la 42765th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Poniard Pharmaceuticals, Inc. desde 1988 hasta 2026
PARD en comparación con los más populares 5 títulos stocks
Precio por PARD Activo B Capital del mercado en B Resultados
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,326 $150.00
$5.426T +3,617,325,682,222.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,951,277 $150.00
$4.427T +2,951,277,314,540.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,759,300 $150.00
$4.139T +2,759,299,687,403.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,437,362 $150.00
$3.656T +2,437,362,459,384.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,923,764 $150.00
$2.886T +1,923,763,906,900.00%